2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization

被引：15

作者：

Harris, Christopher M. ^{[1
]}

Ericsson, Anna M. ^{[1
]}

Argiriadi, Maria A. ^{[1
]}

Barberis, Claude ^{[1
]}

Borhani, David W. ^{[1
]}

Burchat, Andrew ^{[1
]}

Calderwood, David J. ^{[1
]}

Cunha, George A. ^{[1
]}

Dixon, Richard W. ^{[1
]}

Frank, Kristine E. ^{[1
]}

Johnson, Eric F. ^{[1
]}

Kamens, Joanne ^{[1
]}

Kwak, Silvia ^{[1
]}

Li, Biqin ^{[1
]}

Mullen, Kelly D. ^{[1
]}

Perron, Denise C. ^{[1
]}

Wang, Lu ^{[1
]}

Wishart, Neil ^{[1
]}

Wu, Xiaoyun ^{[1
]}

Zhang, Xiaolei ^{[1
]}

Zmetra, Tami R. ^{[1
]}

Talanian, Robert V. ^{[1
]}

机构：

[1] Abbott Labs, Worcester, MA 01605 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 01期

关键词：

MAPKAP-K2; MK2; TNF alpha; Diaminopyrimidine;

D O I：

10.1016/j.bmcl.2009.10.103

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe structure-based optimization of a series of novel 2,4-diaminopyrimidine MK2 inhibitors. Co-crystal structures (see accompanying Letter) demonstrated a unique inhibitor binding mode. Resulting inhibitors had IC50 values as low as 19 nM and moderate selectivity against a kinase panel. Compounds 15, 31a, and 31b inhibit TNF alpha production in peripheral human monocytes. (c) 2009 Elsevier Ltd. All rights reserved.

引用

页码：334 / 337

页数：4

共 50 条

[21] Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents
Zhou, Wenbo
Huang, Anling
Zhang, Yong
Lin, Qingxiang
Guo, Weikai
You, Zihua
Yi, Zhengfang
Liu, Mingyao
Chen, Yihua
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 96 : 269 - 280
[22] Structure-based design and synthesis of novel 2,4-diaminofuro[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee, A
Dubash, NP
Queener, SF
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1169 - U1169
[23] EFFECT OF AN ENZYME BINDING-SITE ON THE ELECTRONIC DISTRIBUTION OF BOUND INHIBITORS - 2,4-DIAMINOPYRIMIDINE IN DIHYDROFOLATE-REDUCTASE
CUTHBERTSON, AF
JOURNAL OF MOLECULAR GRAPHICS, 1985, 3 (04): : 131 - 134
[24] Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group
Milkiewicz, Karen L.
Aimone, Lisa D.
Albom, Mark S.
Angeles, Thelma S.
Chang, Hong
Grobelny, Jennifer V.
Husten, Jean
LoSardo, Christine
Miknyoczki, Sheila
Murthy, Seetha
Rolon-Steele, Damaris
Underiner, Ted L.
Weinberg, Linda R.
Worrell, Candace S.
Zeigler, Kelli S.
Dorsey, Bruce D.
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (21) : 6274 - 6284
[25] An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors
Hedstrom, Ulf
Norberg, Monica
Evertsson, Emma
Lever, Sarah R.
af Rosenschold, Magnus Munck
Lonn, Hans
Bold, Peter
Kack, Helena
Berntsson, Pia
Vinblad, Johanna
Liu, Jianming
Welinder, Anette
Karlsson, Johan
Snijder, Arjan
Pardali, Katerina
Andersson, Ulf
Davis, Andrew M.
Mogemark, Mickael
CHEMMEDCHEM, 2019, 14 (19) : 1701 - 1709
[26] Synthesis and SAR studies of indole-based MK2 inhibitors
Xiong, Zhaoming
Gao, Donghong Amy
Cogan, Derek A.
Goldberg, Daniel R.
Hao, Ming-Hong
Moss, Neil
Pack, Edward
Pargellis, Chris
Skow, Donna
Trieselmann, Thomas
Werneburg, Brian
White, Andre
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1994 - 1999
[27] Fragment-Based Drug Discovery of Novel MK2 Inhibitors
Hesterkamp, Thomas
JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 894 - 895
[28] Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors.: Part 1
Furet, P
Caravatti, G
Denholm, AA
Faessler, A
Fretz, H
García-Echeverría, C
Gay, B
Irving, E
Press, NJ
Rahuel, J
Schoepfer, J
Walker, CV
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2337 - 2341
[29] Stereoselective Synthesis and Antimicrobial Studies of Allo-Gibberic Acid-Based 2,4-Diaminopyrimidine Chimeras
Depp, Dima
Sebok, Noemi Regina
Szekeres, Andras
Szakonyi, Zsolt
PHARMACEUTICALS, 2025, 18 (02)
[30] Inhibitors of the tyrosine kinase EphB4.: Part 1:: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
Bardelle, Catherine
Cross, Darren
Davenport, Sara
Kettle, Jason G.
Ko, Eun Jung
Leach, Andrew G.
Mortlock, Andrew
Read, Jon
Roberts, Nicola J.
Robins, Peter
Williams, Emma J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2776 - 2780

← 1 2 3 4 5 →